PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable device.

The US Food and Drug Administration (FDA) has approved Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for ...

The European Commission (EC) will restrict Chinese firms from EU government purchases of medical devices exceeding €5m ($5.7m ...

Penumbra stands to maintain its market lead and possibly increase its market share as the purchasing of the Ruby XL system ...

GE HealthCare has announced the renewal of its research partnership with Stanford Medicine, US, focusing on the PET/CT ...

GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform ...

Beset by seemingly endless responsibilities, within the UK's NHS and other healthcare systems globally, burnout among GPs is ...

Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response in individuals with ...

Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid ...

GeneCentric Therapeutics has secured $8m in a Series C funding round for its comprehensive liquid biopsy testing system, ...

Grail has reported encouraging top-line performance and safety outcomes from its registrational PATHFINDER 2 study’s ...

Visby Medical has secured around $55m in its funding round to expedite the launch and distribution of its at-home Women's ...